Sponsor:
argenx
Code:
NCT07264426
Conditions
Chronic Inflammatory Demyelinating Polyradiculoneuropathy
CIDP
CIDP (Chronic Inflammatory Demyelinating Polyradiculoneuropathy)
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Efgartigimod PH20 SC
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-01-02. This information was provided to ClinicalTrials.gov by argenx on 2025-12-04.